Kicking the 'counterfeit' out of fake drugs: IOM panel calls for mandatory track-and-trace system in US
This article was originally published in SRA
One of the greatest roadblocks standing in the way of countering the problem of falsified and substandard drugs is the use of the term "counterfeit", argues a US Institute of Medicine panel, which has called for the creation by the Food and Drug Administration of a mandatory track-and-trace system 1.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.